Key facts
- This page summarizes EcoR1 Capital, LLC's Form 4 filing for Corvus Pharmaceuticals, Inc. (CRVS).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 01 Oct 2021, 19:39.
EcoR1 Capital, LLC - 30 Sep 2021 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- CRVS
- Reported as of
- 30 Sep 2021
- Net transaction value
- -$25,059,900
- SEC form
- 4
- Accepted by SEC
- 01 Oct 2021, 19:39:15 UTC
- Prior SEC filing
- 22 Sep 2021
- Next SEC filing
- 18 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- Oleg Nodelman, Manager of EcoR1 Capital, LLC
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
EcoR1 Capital, LLC filed Form 4 for Corvus Pharmaceuticals, Inc. (CRVS) on 01 Oct 2021.
Change
- Previous filing in this sequence was filed on 22 Sep 2021.
- Current net transaction value: -$25,059,900.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRVS
transaction
Common Stock
Sale
- Transaction value
- $15,131,100
- Shares
- -3,000,000
- Change %
- -59%
- Price
- $5.04
- Shares after
- 2,081,077
- Date
- 30 Sep 2021
- Ownership
- See Note 2
- Footnotes
- F1, F2
CRVS
transaction
Common Stock
Sale
- Transaction value
- $9,928,800
- Shares
- -2,000,000
- Change %
- -96%
- Price
- $4.96
- Shares after
- 81,077
- Date
- 01 Oct 2021
- Ownership
- See Note 2
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
EcoR1 Capital, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund") sold 2,643,300 shares of Common Stock in this transaction and held 1,803,513 shares of Common Stock following this transaction.
Footnote F2
The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and Qualified Fund. EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interests therein.
Footnote F3
Qualified Fund sold 1,760,600 shares of Common Stock in this transaction and held 42,913 shares of Common Stock following this transaction.